Dr. Koji Ichiyama is a biologist and certified medical laboratory technologist with extensive expertise in inter-disciplinary research in life sciences. After graduating from Kyorin University and completing his doctoral research in Microbiology-Virology from Tokyo Medical and Dental University under the supervision eminent Virologist Prof. Naoki Yamamoto, he has worked in Molecular pathology department of Columbia University and Dept of Microbiology, National University Singapore. Now he heads the Bench to bedside translation of cell therapies in urology, ophthalmology and orthopedics in collaboration with institutes in Japan and overseas and spearheads the research on rare diseases using exo-polysaccharides with immune modulating potentials. When taking time off from gut microbiomes and phages, he enjoys bird watching, trekking and cycling.
Dr Hiroshi Yoshioka, an eminent polymer chemist whose technological expertise have contributed to solutions in the fields of plant biology, agriculture, animal cell culture, tissue engineering and regenerative medicine. The association with him and his team started in 2002 for corneal regeneration using lab grown stem cells which was awarded a patent in 2009. Continuing collaboration has yielded novel solutions in cell therapy for cartilage repair, in-depth evaluation of matrix based reproducible chemically synthesized environments without animal or foreign protein contamination to augment cell therapy tools in various applications including urology and orthopedics. Recently, studies on cellular senescence and implications of micro-gravity have gained our importance on which a Japanese patent has been granted. Dr. Yoshioka graduated from Waseda University, got his PhD in chemical engineering in 1995. After serving in Terumo Corporation, GRACE Japan and Johnson & Johnson he with Prof Yuichi Mori co-founded Mebiol Inc and serves as its president since 2018. The collaboration with GNC beside solutions using cell therapy, focus on cryopreservation of cells and the transportation of cells and tissues between labs and hospitals to improvise the outcome of clinical applications in regenerative medicine.
Nich-in Centre for Regenerative Medicine (NCRM), the Research & Development partner of GNC is an academic partner to the Training Program in Regenerative Medicine (TPRM) conducted by University of Toronto, since 2006 (https://www.regenmedcanada.com/partners).
Dr Jun Makino of Edogawa Hospital received the completion certificate in NCRM NICHE 2018 held in Tokyo from Dr Masahiro Katoh (Chairman, Edogawa Hospital) joined by Prof. Ian Gallicano of Georgetown University.
Click here to see NCRM NICHE 2018 Award Ceremony
Click here for further information about NCRM TPRM program
At the MENA Conference on Rare DiData presented in IFPA 7th World Psoriasis conference, in Stockholm, Sweden 0
“neu REFIX ” potentials in Duchenne Muscular Dystrophy will be presented at Congress held in UAE
“Nichi Glucan” and “Nichi BRITE” potentials will be presented at an academic conference in Osaka, Japan
A curiosity driven sojourn, across disciplines in science, led to the discovery of a safe adjuvant hidden in a beta glucan giving hope to patients with muscular dystrophy; A story of ZeitenWende all along, blessed with good people, hopefully a modest contribution to humanity by connecting the dots.
